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1. Introduction 
The mechanism of adjuvant activity is extremely 
complex, involving the antigen itself and the host [l] . 
It has been shown that different adjuvants may act on 
macrophages, B and T cells [2] and it has been observed 
that adjuvants can induce preferably IgM or IgG 
antibody stimulation depending upon the adjuvant 
used [3,4]. However it is difficult to understand why 
some adjuvants can act preferentially on one of these 
cells and at what level of the cell this activity is 
expressed. Since Concanavalin A (Con A) is known to 
stimulate lymphocytes [5,6] and peptidoglycans to 
stimulate also the immune response [7,8] we designed 
an in vitro system to test both adjuvants. 
Since lectins, which are known to bind glycopro- 
teins of the cell membrane surface, have in some 
instances adjuvants activity [6,9,10] it can been 
hypothetized that adjuvants could play a role at the 
plasma membrane level. This hypothesis is substantiated 
by the fact that a glycopeptide from M. tuberculosis 
which has adjuvant activity binds IgGz and cellular 
surfaces [ 1 I] and induce preferentially an IgGz anti; 
body response [ 121. It is also known that mitogens 
induce enhancement of membrane functions such as 
fluxes of amino-acids [ 131, K’ [ 14,151, Ca++ [ 161 and 
B. pertussis or poly A-U can inhibit the lymphocyte 
response to cyclic AMP, isoproterenol or prostaglandin 
Er [ 17,181. Thus One of the main problem of 
adjuvant activity would be to understand how 
adjuvants can activate the cell membrane. In order to 
North-Holland Publishing Company - Amsterdam 
answer this question, we should work with a pure cell 
population, which is not possible with the immune 
system, and we should avoid secondary interactions 
between the plasma membrane and the cytoplasm. 
Thus we should purify the cell plasma membrane and 
in a preliminary report we have shown that using a 
Con A-bovine serum albumine copolymer it is possible 
to separate inside-out (1.0.) and right side-out (R.S.O.) 
membrane vesicles [ 191. This study was undertaken 
to examine the effect of two different adjuvants on 
the cell plasma membrane enzymatic activities: we 
expected to observe the stimulation of enzymes in a 
certain range of doses. 
2. Materials and methods 
2.1. Cells 
MFzs cells derived from the murine MOPCr,s 
plasmocytoma [20]. They were adapted to grow as 
ascitis in Balb/c mice. The preparation of the cells has 
been described [ 191. 
2.2. Plasma membranes purification 
The technique has been described elsewhere [21]. 
2.3. Isolation of I. 0. and R.S. 0. plasma membrane 
vesicles 
The technique has been already described [ 191. 
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2.4. Determination of enzymatic activities 2.8. Labelling vesicles 
Enzymatic assays were performed with 66 pg of 
protein per ml of incubation medium. 5’-nucleotidase 
(EC 3.1.3.5) activity was measured by the method of 
Emmelot and Bos [22]. (Na’ + K’) stimulated Mg++- 
ATPase (EC 3.6.1.3) was measured by a slight moditi- 
cation of the Bakkeren and Bonting method [23]. 
Protein concentration was estimated [24] and phos- 
phorus measured by a modification of the Marsh tech- 
nique [25]. 
40 pg of proteins were taken for either 1.0. or 
R.S.O. vesicles and were incubated in a buffer contain- 
ing from 0.05 to 0.8 pg of labelled Con A and incubated 
at 37°C for 30 min. The incubated membranes were 
then put on a 0.22 pm Millipore filter and extensively 
washed. After drying, the filters were put in vials and 
counted in an Intertechnique scintillation counter. 
3. Results 
2.5. Sialic acid determination 
The total amount of sialic acids was estimated by 
the Warren technique [26]. Specific measurements of 
the exposed sialic acid were done by adding 50 pg of 
the Cl. perfringens neuraminidase to 1 mg of mem- 
brane protein (EC 3.2.1.18 Sigma). 
2.6. Adjuvants 
Con A from Calbiochem was used. A peptidoglycan 
extracted by acetylation of delipidated cells from 
M tuberculosis, var. hominis, strain Ha, Ra was 
finally purified by two successive filtrations on Biogel 
P 10 [7,27]. It has a mol. wt. around 3500 and its com- 
position is as following (molar ratios between paren- 
thesis): Ala (3); Glu (2); DAP (2); GlcN (2); Mur 
(2); this substance yet contained 20% sugars (Ara, Man, 
Gal). 
2.7. Labelled Con A 
Right side-out vesicles were characterized by three 
criteria (table 1). The total amount of sialic acids 
estimated by acid hydrolysis was found to be 120 
nmol per mg of protein in R.S.O. vesicles and 
125 nmol per mg of protein in 1.0. vesicles. Release 
by neuraminidase was twice higher in R.S.O. vesicles 
than in 1.0. vesicles i.e. 1 lo- 120 nmol/mg of protein 
and 50-60 nmol/mg of protein respectively. Thus we 
can assume that the relative large amount of free 
sialic acids found in 1.0. could be due to a partial 
permeability (or holes) of the vesicles to the enzyme. 
[3 H] acetyl Con A (specific activity 4600 cpm/pg 
of protein) was a gift from Dr M. Monsigny. 
The total amount of bound labelled Con A was 
about 3% of the incubated amount for R.S.O. and 
less than 2% for 1.0. This clear cut result shows that 
in contrast to the neuraminidase, the large mol. wt 
Con A (50 000 daltons) is not able to penetrate the 
1.0. vesicles even after 30 min incubation. 
From 10 different plasma membrane isolations, 
20 separations of vesicles populations were performed: 
Table 1 
Properties of three different subpopulations of MOPC 173 plasma membranes 
Material 
Sialic acid (mmol/mg Specific activity &mol Pi 
Proteins 
protein 
Bound Con 
A (% incu- 
liberated/hr~mg protein 
(mg) Total Released by 
bated 
5’-nucleot- (Nd + K’) 
amount neuraminid- 
amount) 
idase ATPase 
ase 
Purified 
plasma 
membranes 100 104* 7 65 f 5 n.d. 15 6.3 
IO. ve- 
sicles 40 f 5 127 * 10 Ok5 < 2% 21 9 
R.S.O. 
vesicles 40 f 5 121 f 8 llO+ 8 # 30% 8.5 3.6 
-~- 
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Fig.1. Modulation of the 5’-nucleotidase (o-o-o) and (Na’ + 
K’) stimulated Mg” ATPase (b--b-~) activities by adding 
various amounts of Con A to R.S.O. (left) or 1.0. (right) 
vesicles. The relative specific activity is the ratio between the 
specific activity in presence of Con A and the specific activity 
in absence of Con A. 
the specific activities of 5’-nucleotidase and (Na’ t K+) 
stimulated Mg” ATPase, expressed in I.tmol Pi/hr/mg 
of protein were for a given experiment respectively 
21 and 9 for 1.0. vesicles and 8.5 and 3.6 for R.S.O. 
vesicles. In all instances, total activities recovered in 
both populations represented about 80% or the total 
activities found in the original purified membranes. 
From these results we can deduce that R.S.O. are at 
least permeable to ATP and AMP. 
To 40 fig of plasma membrane proteins increasing 
amounts of Con A from 0.1 to 1 pg were added; the 
mixtures were then incubated for 30 min at 37°C. 
Fig. 1 illustrates the dose-dependant modulation of 
both enzymatic activities under study when Con A is 
added either to 1.0. or to R.S.O. vesicles. Whereas 
1.0. vesicles showed no modification of the enzymatic 
activities whatever was the dose of Con A, R.S.O. 
expressed a biphasic reaction for both enzymes: from 
0.1 to 0.4 Erg of Con A, the 5’nucleotidase and the 
(Na’ t K> stimulated Mg” ATPase increased from 
100 to 130- 160%, while from 0.5 to 1 pg of Con A 
the activity came down to 40%. We would like to 
stress the point that with some batches of Con A, with 
the same amount of lectin, increase reached 200%. 
The calculations showed that 1 Or* molecules stimulat- 
ed activities whereas 510’* and over inhibited them. 
Fig.2 illustrates the dose dependant modulation 
of the same enzymatic activities when the peptido- 
glycan is incubated with either 1.0. or R.S.O. vesicles, 
the procedure being the same as above. In this case, 
R.S.O. were not reactive at all i.e. both enzymatic 
activities stayed at the same level whatever was the 
dose of adjuvant added, between lo-** to lo-’ 
/.qg/ml. In contrast 1.0. vesicles showed a biphasic 
reaction for both enzymes: increase to 120- 150% 
was observed between 10m9 and lo-’ &ml where 
inhibition occurred between 10m6 to 10m3 pg/ml. The 
calculations showed that only 2.10’ -2.10’ molecules 
stimulated whereas 2.1 O* -2.10” inhibited the acti- 
vities. 
4. Discussion 
From these results we can conclude that our pro- 
cedure allowed us to separate 1.0. and R.S.O. vesicles 
characterized mainly by the fact that glycoproteins 
are exposed only in R.S.O. Thus it is understandable 
that Con A is acting only on R.S.O. and not at all on 
1.0. R.S.O. are permeable to neuraminidase to AMP 
and ATP not to Con A which would mean that 
vesicles are not closed but have only small holes. It 
is important to notice that both enzymes are modulat- 
ed with the same dose curve which lead us to 
hypothetize that either Con A has a non specific effect 
Fig.2. Modulation of the 5’-nucleotidase (o-o-o) and (Na’+ 
K’) stimulated MgH ATPase (A-AA) activities by adding 
various amounts of acetylated peptidoglycan-like adjuvant o 
R.S.O. (left) or 1.0. (right) vesicles. 
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i.e. by modifying the membrane structure, or that, 
as both enzymes could be glycoproteins [28,29] Con A 
has a direct effect on the enzymatic activities. Con A 
is known to induce patching and sometimes capping 
[30,31] and this has been shown to be true in the 
case of different variants of our culture cell lines [32]. 
We would favor the idea that depending upon the 
percentage of the binding sites of the surface mem- 
brane bound by the lectin, structural changes differ so 
that the enzyme activities would be enhanced or 
inhibited in a non specific way. This figure would 
mimic antigenic stimulation or inducement of 
tolerance depending upon the percentage of specific 
receptors bound [33,34]. It is important to emphasize 
the fact that in contrast to Con A the acetylated 
peptidoglycanlike adjuvant is active on 1.0. and not 
on R.S.O. As this adjuvant was extracted from a lipid 
rich fraction, it can be assumed that the molecule 
should reach the lipidic moiety of the cell membrane 
in order to be active and that 1.0. vesicles allow 
easily the molecule to penetrate the membrane whe- 
reas R.S.O. do not. We have to study where is sitting 
the molecule into the membrane for an understanding 
of its activity. 
For both adjuvants we observed with low and high 
doses enhancement and inhibition respectively for both 
5’nucleotidase and (Na’ t K+) stimulated Mg” ATPase. 
We could hypothetize that adjuvants could be stimulat- 
ing or inhibiting depending upon the dose used. The 
stimulating effect is well documented as well at the 
host or the cell level [2] and inhibition has also been 
described at the host [35,36] and the cell level [6,37]. 
The membrane vesicles seem to be an extremely 
sensitive test as it requires much less active product 
to test its activity: 1 O-’ g of Con A is enough 
compared to 10-5-10-6 gin tissue culture [6,37] ; 
1 O-l6 g of peptidoglycan-like substance was revealed 
in our system compared to 1 O-8-1O-9 g on cell 
macrophages [38,39]. In this last example, we do not 
know how so low doses are still active. 
The results presented here seem to indicate that 
our procedure could be used to screen adjuvants. It 
seems that Con A and the peptidoglycan while acting 
at two different levels of the plasma membrane, 
induce both a biphasic modulation of 5’nucleotidase 
and of the (Na’ t K+) stimulated Mg++ ATPase: this 
result is in favor of an indirect effect of the adjuvants 
on the enzymatic activities. 
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